賽生藥業(06600.HK)：建議市場上股份購回計劃

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

賽生藥業(06600.HK)：建議市場上股份購回計劃

格隆匯 03-31 00:05

格隆匯3月31日丨賽生藥業(06600.HK)發佈公吿，董事會已批准行使股份購回授權，以於適當時候從公開市場購回公司股份的計劃。根據股份購回授權，公司獲許購回最多6842.99萬股股份，佔公司於股東周年大會當日於聯交所已發行股份總數的10%。

於該公吿日期，已根據股份購回授權購回及註銷300.9萬股股份。進行建議股份購回計劃時，董事會將行使股份購回授權，同時按上市規則的規定維持足夠公眾持股量。建議股份購回計劃的批准期限不會超過該公吿日期起計12個月。

賽生藥業(06600.HK)

Relevant Stocks

賽生藥業(06600.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

賽生藥業(06600.HK)：建議市場上股份購回計劃

Services

About Us

Agreement Statement